TABLE 1.
Demographic and focal epileptic characteristics in the ITT population
|
OXC group n = 118 |
LEV group n = 109 |
p‐value | |
|---|---|---|---|
| Age (years), median (IQR) | 37 (26–51) | 32 (24–45) | 0.070 |
| Gender, n (%) | |||
| Male | 65 (50.9%) | 53 (58.4%) | 0.403 |
| Female | 53 (49.1%) | 55 (41.6%) | |
| Weight (Kg), mean±SD | 61.94±9.70 | 61.39±9.89 | 0.672 |
| Duration of epilepsy (month), median (IQR) | 10.5 (3–50.25) | 17 (4–66) | 0.396 |
| Numbers of seizures per month, median (IQR) | 1 (0.667–2) | 1 (0.667–2.333) | 0.601 |
Abbreviations: IQR, interquartile range; ITT, intention‐to‐treat; Kg, kilogram; LEV, levetiracetam; OXC, oxcarbazepine; SD, standard deviation. p < 0.05 was accepted as significant.